Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Official title:
Patient-Centered Physical Activity Coaching in COPD: A Pragmatic Trial
Chronic obstructive pulmonary disease (COPD) is the third leading cause of the death in the
US. The personal, social and economic costs of the disease are tremendous, with annual
expenditures of nearly $50 billion, mostly from hospitalizations for exacerbations of COPD
and associated sequelae. For the vast majority of patients, despite optimal pharmacological
therapy, living with COPD is characterized by unrelieved dyspnea, physical inactivity,
deconditioning, and an insidious downward spiral of social isolation and depression that has
a profound impact on the lives of patients and their caregivers. There is mounting evidence
that physical inactivity is significantly associated with more frequent hospitalizations and
increased mortality in COPD even after adjusting for disease severity.
While practice guidelines recommend regular physical activity for all patients with COPD,
health systems are challenged in operationalizing an effective and sustainable approach to
assist patients in being physically active. The investigators propose a pragmatic randomized
controlled trial to determine the effectiveness of a 12-month physical activity coaching
intervention (Walk On!) compared to standard care for 1,650 COPD patients from a large
integrated health care system.
Physical inactivity is significantly associated with more frequent hospitalizations and
increased mortality in COPD even after adjusting for disease severity. While practice
guidelines recommend regular physical activity for all patients with COPD, health systems are
challenged in operationalizing an effective and sustainable approach to assist patients in
being physically active.
A pragmatic randomized controlled trial design will be used to determine the effectiveness of
a 12-month home and community-based physical activity coaching intervention (Walk On!)
compared to standard care for 2,700 COPD patients from a large integrated health care system.
Eligible patients with a COPD-related hospitalization, emergency department visit, or
observational stay in the previous 12 months will be automatically identified from the
electronic medical records (EMR) system and randomized to treatment arms. The Walk On!
intervention includes collaborative monitoring of step counts, semi-automated step goal
recommendations, individualized reinforcement from a physical activity coach, and peer/family
support.
The primary composite outcome includes all-cause hospitalizations, emergency department
visits, observational stays, and death in the 12 months following randomization. Secondary
outcomes include COPD-related utilization, cardio-metabolic markers, physical activity,
symptoms, and health-related quality of life. With the exception of patient reported
outcomes, all utilization and clinical variables will be automatically captured from the EMR.
If successful, findings from this multi-stakeholder driven trial of a generalizable and
scalable physical activity intervention model, carefully designed with sufficient
flexibility, intensity, duration, and support for a large ethnically diverse sample could
re-define the standard of care to effectively address physical inactivity in COPD.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03282019 -
Study of Long-term HFNC for COPD Patients With HOT
|
N/A | |
| Completed |
NCT05573464 -
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
| Recruiting |
NCT06040086 -
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
|
Phase 3 | |
| Not yet recruiting |
NCT06376994 -
Multi-Center Clean Air Randomized Controlled Trial in COPD
|
Phase 3 | |
| Completed |
NCT02728674 -
Management of Patients With Respiratory Symptoms in Sweden
|
N/A | |
| Completed |
NCT02926534 -
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
N/A | |
| Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
| Recruiting |
NCT02415478 -
Bronchioscopic Lung Volume Reduction (BLVR)
|
N/A | |
| Completed |
NCT02518139 -
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT02459080 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT02512510 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT02774226 -
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
| Completed |
NCT03487406 -
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
|
Phase 2 | |
| Completed |
NCT01893476 -
A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
|
N/A | |
| Completed |
NCT01908140 -
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
| Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
| Completed |
NCT01701869 -
Microbiology & Immunology of the Chronically-inflamed Airway
|
N/A | |
| Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
| Withdrawn |
NCT01377428 -
Efficacy of Indacaterol 150 µg Versus Formoterol
|
Phase 4 |